Incidence of thrombosis in adults with acute leukemia: A single center experience in Mexico

Revista de Investigacion Clinica

Volumn 65, Issue 2, 2013, Pages 130-140

  Guzmán Uribe, Patricia ^a   Rosas López, Adriana ^a   Zepeda León, Jonathan ^a   Crespo Solís, Erick ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Acute; Adults; Leukemia; Survival; Thrombosis

Indexed keywords

ASPARAGINASE;

ACUTE HEART INFARCTION; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CANCER CHEMOTHERAPY; CATHETER THROMBOSIS; CAUSE OF DEATH; CENTRAL VENOUS CATHETER; CLINICAL FEATURE; COHORT ANALYSIS; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEXICO; MORTALITY; OVERALL SURVIVAL; PROMYELOCYTIC LEUKEMIA; RETROSPECTIVE STUDY; SURVIVAL RATE; THROMBOSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; LEUKEMIA; MALE; MEXICO; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBOSIS; YOUNG ADULT;

EID: 84879579023     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Bick RL, Strauss FJ, Frenkel PE. Thrombosis and hemorrhage in oncology patients. Hematol Oncol Clin North Am 1996; 10: 875-907. (Pubitemid 26240364)
2. Connolly G, Khorana A. Emerging Risks stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score. Thromb Res 2010; 125 (Suppl. 2): S1-S7.
3. Khorana A. Venous Thromboembolism and prognosis in cancer. Thromb Res 2010; 125: 490-3.
4. Hillen HF. Thrombosis in Cancer Patients. Ann Oncol 2000; 11 (Suppl. 3): 273-6.
5. Lee AY, Levine MN. Venous thromboembolism and cancer: Risks and outcomes. Circulation 2003; 107: 117-121.
6. Falanga A, Marchetti M. Venus Thromboembolism in the Hematologic Malignancies. J Clin Oncol 2009; 27: 4848-57.
7. Khorana AA, Francis CW, Culakova E, Kuderer NM, et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemostasis 2007; 5: 632-4. (Pubitemid 46680709)
8. Kolitz JE, Rakel RE, Bope ET. Acute leukemias in adults. In: Conn's Current Therapy. Saunders 2008; 6: 441-6.
9. Falanga A, Rickles FR. Management of thrombohemorrhagic syndromes (THS) in hematologic malignancies. Hematology Am Soc Hematol Educ Program 2007; 165-71.
10. Ziegler S, Sperr WR, Knöbl P, Lehr S, et al. Symptomatic venous thromboembolism in acute leukemia: incidence, risk factors, and impact on prognosis. Thromb Res 2005; 115: 59-64. (Pubitemid 39572756)
11. Mohren M, Markmann I, Jentsch-Ullrich K, Koenigsmann M, et al. Increased Risk of venous thromboembolism in patients with acute leukemia. Br J Cancer 2006; 94: 200-02. (Pubitemid 43151535)
12. Ku G, White R, Chew H, Harvey DJ, et al. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood 2009; 113: 3911-7.
13. De Stefano V, Sora F, Rossi E, Chiusolo P, et al. The risk of thrombosis in patients with acute leukemia: Occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost 2005; 3: 1985-92. (Pubitemid 43086055)
14. Melillo L, Grandon E, Colaizzo D, Cappucci F, et al. Symptomatic venous thromboembolism and thrombophilic status in acute adult leukemia: A single-center experience of 114 patients at diagnosis. Acta Haematol 2007; 117: 215-20. (Pubitemid 46788230)
15. Wun T, White RH. Venous Thromboembolism in patients with acute leukemia, lymphoma and multiple myeloma. Thromb Res 2010; 125 (Suppl. 2): S96-S102.
16. Crespo-Solis E. Thrombosis in acute leukemia. Hematology 2012; (Suppl. 1); 17: S169-S173.
17. Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, et al. Annexin II and bleeding in acute promyelocitic leukemia. N Engl J Med 1999; 340: 994-1004. (Pubitemid 29157631)
18. Kasthuri RS, Taubman MB, Mackman N. Role of Tissue Factor in Cancer. J Clin Oncol 2009; 27: 4834-8.
19. Vargas-Ruiz A. Cáncer y Trombosis. Rev Herno Trombo 2010; 3: 1-12.
20. Matzdorff AC, Green D. Overview of Cancer and Thrombosis. In: Rosen ST, Green D, Kwaan HC. Coagulation in cancer. 1st. Ed USA: Springer; 2009, p. 83-94.
21. Harlev D, Zaidman I, Sarig G, Ben Arush MW, et al. Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment. Thromb Res 2010; 126: 93-7.
22. Nowak-Göttl U, Heinecke A, Von Kries R, Nürnberger W, et al. Thrombotic events revisited in children with acute lymphoblastic leukemia. Impact of concomitant Escherichia coli asparaginase/prednisone administration. Thromb Res 2001; 103: 165-72. (Pubitemid 32728101)
23. Rickles F, Falanga A, Montesinos P, Sanz MA, et al. Bleeding and thrombosis in acute leukemia: What does the future of therapy look like? Thromb Res 2007; 120 (Suppl. 2): S99-S106. (Pubitemid 350110475)
24. Khorana A, Connolly G. Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol 2009; 27: 4839-47.
25. Connolly GC, Khorana AA, Kuderer NM, Culakova E, et al. Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy. Thromb Res 2010; 126: 113-8.
26. Ramos Peñafiel CO, Martínez Murillo C, Castellanos Sinco H, Montaño Figueroa E, et al. Frecuencia de trombosis venosa en pacientes con Leucemia Linfoide Aguda durante la terapia de inducción: Protocolo Institucional HGMLAL 07/09. Rev Hemo Trombo 2012; 3: 1-5.
27. Swerdlow SH, Campo E, Harris NL, et al (eds.): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC: Lyon; 2008.
28. Byrd J, Mrozek K, Dodge R, Carroll AJ, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse and overall survival in adult patients with the novo acute myeloid leukemia: results from Cancer and Leukemia Group B, CALGB 8461. Blood 2002; 100: 4325-36. (Pubitemid 35429670)
29. Omura G, Vogler R, Lefante J, Silberman H, et al. Treatment of acute myelogenus leukemia: Influence of three induction regimens and manteinance with chemotherapy and manteinance of BCG immunotherapy. Cancer 1982; 49: 1530-6. (Pubitemid 12146936)
30. Buitrón-Santiago N, Arteaga-Ortiz L, Rosas-López A, Aguayo A, et al. Experiencia del INCMNSZ en pacientes adultos con leucemia mieloide aguda. Cohorte 2003-2008. Rev Invest Clin 2010; 62: 100-08.
31. Thomas D, Cortes J, O'Brien S, Pierce S, et al. Hyper-CVAD Program in Burkitt's-Type Adult Acute Lymphoblastic Leukemia. J Clin Oncol 1999; 17: 2461-70. (Pubitemid 29368246)
32. Arteaga-Ortiz L, Buitrón-Santiago N, Rosas-López A, Rosas-Arzate G, et al. Experiencia del INCMNSZ en pacientes adultos con leucemia linfoide aguda. Cohorte 2003-2007 con esquemas de tratamiento Hiper-CVAD y Protocolo 0195. Rev Invest Clin 2008; 60: 459-69.
33. Sanz MA, Martin G, Gonzalez M, León A, et al. Risk adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group. Blood 2004; 103: 1237-43. (Pubitemid 38168633)
34. Cortelezzi A, Moia M, Falanga A, Pogliani EM, et al; CATHEM Study Group. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study. Br J Haematol 2005; 129: 811-17. (Pubitemid 40904533)
35. Rooden CJ, Tesselaar MET, Osanto S, Rosendaal FR, et al. Deep vein thrombosis associated with central venous catheters - a review. J Thromb Haemost 2005; 3: 2409-19. (Pubitemid 41727156)
36. Payne JH, Vora AJ. Thrombosis and acute lymphoblastic leukemia. Br J Haematol 2007; 138: 430-45.
37. Korte W, Fletges A, Baumgartner C, Ullmann S, et al. Increased thrombin generation during fibrinogen and platelet recovery as an explanation for hypercoagulability in children with L-asparaginase therapy for ALL or NHL: a preliminary report. Klin Padiatr 1994; 206: 331-3. (Pubitemid 24248175)
38. Sutor AH, Mall V, Thomas KB. Bleeding and thrombosis in children with acute lymphoblastic leukemia, treated according to the ALL-BFM-90 protocol. Klin Padiatr 1999; 211: 201-04. (Pubitemid 29364756)
39. Hunault-Berger M, Chevallier P, Delain M, Bulabois CE, et al GOELAMS (Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang). Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma: use of supportive coagulation therapy and clinical outcome. The CAPELAL study. Haematologica 2008; 93: 1488-94.
40. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arc Int Med 2000; 160: 3415-20.
41. Ay C, Vormittag R, Dunkler D, Simanek R, et al. D-Dimer and prothrombin fragment 1+2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol 2009; 27: 4124-9.
42. Montesinos P, De la Serna J, Vellenga E, et al. Incidence and risk factors for thrombosis in patients with acute promyelocytic leukemia. Experience of the PETHEMA LPA96 and LPA99 protocols. Blood (ASH Annual Meeting Abstracts) 2006; 108: 1503.
43. Dally N, Hoffman R, Haddad N, Sarig G, et al. Predictive Factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia - a single center experience in 34 patients. Thromb Res 2005; 116: 109-14. (Pubitemid 40720186)
44. Breccia M, Avvisati G, Latagliata R, Carmosino I, et al. Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features. Leukemia 2007; 21: 79-83. (Pubitemid 44921838)
45. Athale UH, Chan AKC. Thrombosis in children with acute lymphoblastic leukemia. Part I. Epidemiology of thrombosis in children with acute lymphoblastic leukemia. Thromb Res 2003; 11: 125-31. (Pubitemid 37532849)
46. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000; 343: 1846-50. (Pubitemid 32104130)
47. Kuderer NM, Ortel TL, Francis CW. Impact of Venous Thromboembolism and Anticoagulation on Cancer and Cancer Survival. J Clin Oncol 2009; 27: 4902-11.